Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Brain Neoplasms 3Recurrence 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Glioblastoma 2Carcinoma, Squamous Cell 2Squamous Cell Carcinoma of Head and Neck 1Skin Squamous Cell Cancer 1Rare Tumor 1Penile Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1NSCLC 1Lung Neoplasms 1Carcinoma 1Advanced Gastric Cancer 1

Interventions

Oxaliplatin 67Capecitabine 60Fluorouracil 58Bevacizumab 54Gemcitabine 51Paclitaxel 50Leucovorin 50Irinotecan 40Docetaxel 39Carboplatin 39Cisplatin 38pembrolizumab 37Nivolumab 37Cetuximab 35Sunitinib 25Trastuzumab 24Radiosurgery 24Radiotherapy 21Doxorubicin 21Cyclophosphamide 21Panitumumab 20Drug Therapy 19Pemetrexed 18Everolimus 18Sorafenib 17Interleukin-2 16Fulvestrant 16Albumin-Bound Paclitaxel 16atezolizumab 15Erlotinib Hydrochloride 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Metastasis × dacomitinib × Clear all
NCT02047747 2016-09-22

A Phase II Study of Dacomitinib in Progressive Brain Metastases

University of California, San Diego

Phase 2 Terminated
4 enrolled 4 charts
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT00769067 2015-10-07

A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen

Pfizer

Phase 2 Completed
188 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡